| Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845) |
|---|
| 01/02/2003 | US20030004333 Contacting chemical intermediate with sulfuric acid |
| 01/02/2003 | US20030004214 Irritable bowel disease |
| 01/02/2003 | US20030004147 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/02/2003 | EP1268511A1 Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst |
| 12/19/2002 | WO2002101014A2 A process for making estra-4,9(10)-diene steroids |
| 12/19/2002 | WO2002100881A1 Process for the synthesis of oxandrolone |
| 12/19/2002 | WO2002100878A1 Preparation of flumethasone and its 17-carboxyl androsten analogue |
| 12/19/2002 | WO2002100877A1 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/19/2002 | US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number |
| 12/12/2002 | WO2001042272A9 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 12/11/2002 | EP0929566B1 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives |
| 12/11/2002 | CN1384111A Extraction process of hecogenin from Yunnan hemp |
| 12/05/2002 | US20020183294 Therapy and prophylaxis of cognitive dysfunction in a human or non-human animal by administering sapogenin derivatives wherein the E and/or F ring of the fused ring system has been cleaved |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 12/03/2002 | US6489134 Kinesin motor modulators derived from the marine sponge Adocia |
| 12/03/2002 | US6488960 Corticosteroid formulation |
| 11/28/2002 | US20020177581 Novel anti-inflammatory androstane derivative |
| 11/27/2002 | CN1381464A Antineoplastic compound intercedenside A |
| 11/21/2002 | WO2002092085A1 Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 11/21/2002 | US20020173496 Formulation containing novel anti-inflammatory androstane derivative |
| 11/14/2002 | US20020168427 Plant extract |
| 11/13/2002 | EP1255553A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers |
| 11/07/2002 | WO2002088169A2 Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives |
| 11/07/2002 | US20020165221 Cellular antigrowth agents |
| 11/07/2002 | US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 10/30/2002 | EP1251856A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 10/30/2002 | CN1377368A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 10/30/2002 | CN1377367A Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 10/30/2002 | CN1377366A 5-hydroxysapogenin derivatives with anti-dementia activity |
| 10/30/2002 | CN1377365A Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 10/24/2002 | WO2002047667A3 Novel medicament compositions based on anticholinesterase drugs and on a steroid |
| 10/24/2002 | US20020156271 19-nor-17alpha-pregna-1,3,5 (10) -trien-17beta-ols with a 21, 16alpha-lactone ring |
| 10/23/2002 | EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 10/17/2002 | WO2002080930A1 Intermittent lowering of levels of cortisol and other adrenalhormones as treatment of clinical conditions associated with abnormal concentrations of such hormones in man and animals |
| 10/16/2002 | EP1248627A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 10/10/2002 | WO2002079221A2 Sapogenin derivatives, their synthesis and use |
| 10/10/2002 | CA2442150A1 Sapogenin derivatives, their synthesis and use, and methods based upon their use |
| 10/09/2002 | EP1246835A2 Substituted sapogenins and their use |
| 10/03/2002 | WO2002077008A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 10/03/2002 | US20020143001 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 10/02/2002 | EP0944644B1 PROCESSES FOR PREPARATION OF 3-KETO-7alpha-ALKOXYCARBONYL-delta-4,5- STEROIDS AND INTERMEDIATES USEFUL THEREIN |
| 10/02/2002 | CN1372565A Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 09/25/2002 | EP1242444A1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/19/2002 | WO2002022646A9 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) |
| 09/18/2002 | EP1240179A2 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 09/18/2002 | EP1056461B1 Glucocorticoids for treating glomerulonephritis |
| 09/12/2002 | WO2002038582A3 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/12/2002 | WO2002038581A3 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/10/2002 | US6448421 Purifying a crude product derivative through a reverse phase chromatography and then crystallizing from an organic solvent; oxy gonane and indene, cyclohexyl derivatives |
| 09/05/2002 | US20020123485 For therapy of hypertension, cirrhosis and ascites |
| 08/29/2002 | WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/27/2002 | CA2032311C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
| 08/20/2002 | US6436918 Sulfamate- and aminocarbonyl- substituted steroid ring system having 4 attached rings; therapeutic and prophylactic treatments for estrogen dependent illnesses. |
| 08/15/2002 | WO2002062302A2 Steroidal derivatives |
| 08/15/2002 | US20020111503 Crystals of vitamin d derivatives and process for the preparation thereof |
| 08/15/2002 | US20020111337 Use of an aldosterone receptor antagonist to improve cognitive function |
| 08/15/2002 | CA2438221A1 Steroidal derivatives |
| 08/14/2002 | EP1087987B1 A compound, wf002, production thereof and use thereof |
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
| 08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/07/2002 | EP1227804A2 Use of an aldosterone antagonist for treating restenosis |
| 08/01/2002 | US20020103391 17-methyleneandrost-4-en-3 alpha-ol for example; anxiolytic agents; ligand semiochemicals which bind to neuroepithelial receptors |
| 07/31/2002 | CN1361112A Halcinonide producing process |
| 07/31/2002 | CN1361111A Furost saponine analogue and its separation process and use |
| 07/25/2002 | DE10055820C1 Preparation of 16,17-cyclohexylmethylene-dioxy-pregnadiene derivative, useful as glucocorticoid, by reacting 16,17-ketal with cyclohexylaldehyde to give high epimeric purity |
| 07/24/2002 | EP1224207A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/24/2002 | EP1224206A1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 07/24/2002 | EP1224205A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 07/24/2002 | EP1224204A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/24/2002 | CN1360590A Androgen glycosides and androgenic activity thereof |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/17/2002 | EP1223174A2 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| 07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | CN1358734A 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 07/09/2002 | US6417350 Esterification of the alcohol derivative with succinic anhydride in alkyl ester solvent using basic catalyst; washing in aqueous acid; separation, filtration, concentration, and precipitation |
| 07/04/2002 | WO2001041535A9 Eplerenone crystalline form |
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 06/20/2002 | WO2002047668A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 06/20/2002 | WO2002047667A2 Novel medicament compositions based on anticholinesterase drugs and on a steroid |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/19/2002 | EP1165596B1 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/13/2002 | WO2001074839A3 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 06/13/2002 | US20020072510 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
| 06/06/2002 | WO2002022646A3 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/06/2002 | US20020068726 Sulfamate- and aminocarbonyl- substituted steroid ring system having 4 attached rings; therapeutic and prophylactic treatments for estrogen dependent illnesses. |
| 06/04/2002 | US6399796 Activation of a Diels-Alder reaction of a sterol 5,7-diene |
| 06/04/2002 | US6399595 Steroid sulfatase inhibitors and methods for making and using the same |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/23/2002 | US20020062021 Fluorinating a 9b, 11b-steroid with N-fluoro-N-chloromethyltriethylenediaminebistetrafluoroborate, 1-fluoro-4-hydroxy-1,4-diazabicyclo(2.2.2)octane bistetrafluoroborate, or 1-fluorobenzenesulfonamide. |
| 05/22/2002 | EP1207166A2 Process for the preparation of 6.alpha.-fluoro,9,11.beta.-epoxy-steroids |
| 05/22/2002 | EP1207165A2 Isomerisation of 6beta-fluorosteroids into the corresponding 6alpha-fluoro derivatives |
| 05/22/2002 | EP0606317B1 Saponin-antigen conjugates and the use thereof |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |